Site Inclusion Criteria

• Site must currently be a FLASCO member.
• Site location contributes appropriately to overall sampling requirements (i.e., study includes at least one partner site from each of the geographic regions [i.e., Northern, Central, or Southern] that contributes to the study sample quotas in terms of diagnosis, sex, race, and ethnicity).
• Site has an adequate volume of eligible patients to contribute to overall sampling quotas.
• Site employs appropriate staff member to serve as study principal investigator (PI).
• Site employs staff with previous experience with research study recruitment.

Site Exclusion Criteria

• Site is currently not a FLASCO member.
• Site location does not contribute appropriately to overall sampling requirements (i.e., study includes at least one partner site from each of the geographic regions [i.e., Northern, Central, or Southern] or does not contribute to the study sample quotas in terms of diagnosis, sex, race, and ethnicity).
• Site does not have an adequate volume of eligible patients to contribute to overall sampling quotas.
• Site does not employ appropriate staff member to serve as study PI. Site does not employ staff with previous experience with research study recruitment.

Participant Inclusion Criteria

For mUC

• Patients who received a clinical diagnosis of mUC within the past 3 months. The diagnosis can be either de novo Stage IV mUC or progressive/recurrent disease after an initial diagnosis of Stage I to III.
• English or Spanish language proficient.
• Currently receives oncology care at a FLASCO member site study partner.
• Age 18 years and older.
• Completes informed consent to participate in the study.

For mBC

• Female patients who received a clinical diagnosis of mBC that is either triple negative (TNBC) (estrogen receptor, progesterone receptor, and HER2 ), HER2-low, or HR+/HER2 within the past 3 months. The diagnosis can be either de novo Stage IV mBC or progressive/recurrent disease after an initial diagnosis of Stage I to III.
• English or Spanish language proficient.
• Currently receives oncology care at a FLASCO member site study partner.
• Age 18 years and older.
• Completes informed consent to participate in the study.

Participant Exclusion Criteria

​​​​​​​For mUC

• Is not a patient who received a clinical diagnosis of mUC within the past 3 months
• Is not English or Spanish language proficient.
• Does not currently receive oncology care at a FLASCO member site study partner.
• Is under 18 years of age.
• Does not consent to participate in the study.

For mBC

• Is not a female patient who received a clinical diagnosis of mBC that is either triple negative (TNBC) (estrogen receptor, progesterone receptor, and HER2 ), HER2-low, or HR+/HER2 within the past 3 months.
• Is not English or Spanish language proficient.
• Does not currently receive oncology care at a FLASCO member site study partner.
• Is under 18 years of age.
• Does not consent to participate in the study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/08/2024. Questions regarding updates should be directed to the study team contact.